DOSSIER · 13F Holders · Q2 2026
IKT
INHIBIKASE THERAPEUTICS INC
115 institutions still hold INHIBIKASE THERAPEUTICS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 45719W205·115 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
115 institutions reported IKT in Q2 2026. Sands Capital Alternatives, LLC leads at 11.4% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 6
95 more holders available. Log in →